Eva Roth

Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases

Christian Koelsche, Daniel Schrimpf, Lars Tharun et al. · Clinical Sarcoma Research · 2017 · 79 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Establishment of a patient-derived orthotopic osteosarcoma mouse model

Claudia Blattmann, Markus Thiemann, Albrecht Stenzinger et al. · Journal of Translational Medicine · 2015 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +15

The K+ Channel Opener 1-EBIO Potentiates Residual Function of Mutant CFTR in Rectal Biopsies from Cystic Fibrosis Patients

Eva Roth, Stephanie Hirtz, Julia Duerr et al. · PLoS ONE · 2011 · 46 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparib

Christopher L. Heidler, Eva Roth, Markus Thiemann et al. · International Journal of Cancer · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model

Claudia Blattmann, Matthias Thiemann, Albrecht Stenzinger et al. · Strahlentherapie und Onkologie · 2013 · 18 citations

Medicine, Cancer Biology, Oncology +12